my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs). The Company's proprietary more
Generex Biotechnology Corporation announced that it has entered into an exclusive Product Licensing & Distribution Agreement with PMG S.A. (www.pmgpharma.com) for the registration, marketing, distribution and sale of Generex Oral-lyn™, the Company’s proprietary buccal insulin spray product, in Chile more
Generex Biotechnology Corporation announced that it has named Craig Eagle, M.D. to its scientific advisory board. Dr. Eagle brings a wealth of oncology experience to help the Company’s wholly-owned subsidiary, Antigen Express, Inc., dba “Generex Oncology”, further its synthetic cancer and influenza more
Generex Biotechnology Corporation announced that it has created a scientific advisory board in an effort to further its drug development programs, specifically in the areas of oncology and metabolic diseases. Management of Generex has been in late stage talks with a number of key industry leaders i more
What will this decade hold for leading anti-cancer drugs and that therapeutic market? Our new report shows you anti-cancer drug revenue forecasts for 2011 to 2021. We provide research, data and opinions to benefit your work now. What revenues will cancer treatment markets generate from 2011 to 2021 more
How will the drug delivery sector develop from 2010, and where will you find the greatest opportunities? How will technology suppliers and drug companies benefit? We show you opportunities for revenue growth for suppliers and users of drug delivery technologies. You can have our report today, stayin more
HOME | CONTACT US | LOGIN | REGISTER Login Email Id Password Forgot Password? | Register Generex in the NEWS SmartPlanet.com - June 15th, 2 ... - Tuesday, Jun 15, 2010 WSOC-TV Channel 9 (Charlotte, ... - Friday, Mar 26, 2010 Helium Health and Fitness - Ma ... - Wednesday, Mar 17, 2010 Dr. Ber more
Antigen Express is a platform and product-based company developing proprietary vaccine formulations for large, unmet medical needs. » read more about us 5/18/2010 GENEREX BIOTECHNOLOGY ANNOUNCES PUBLICATION OF NOVEL IMMUNOTHERAPEUTIC CANCER VACCINE RESULTS IN PATIENTS WITH PROSTATE CANCER 3/2/20 more
virosome, virosom, virosomes, virosomal, Pevion Biotech, experts in vaccine design HOME l CORPORATE OVERVIEW l PRODUCTS l VIROSOME TECHNOLOGY l INVESTORS l CAREERS l NEWS l News 26.04.2010 Pevion announces excellent preclinical results for PEV4 RSV Vaccine candidate News 22.03.2010 Pevion B more
Watchlist
This is where you can add this topic to your personal favourites
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
